Registry study for people with Bardet-Biedl syndrome
Part of Brain & nervous system, Eyes & vision, Genetic & congenital clinical trials.
This study is a registry that collects health and genetic information from people with Bardet-Biedl syndrome. It may help researchers better understand the condition and improve future care by building a clear group of eligible patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have genetic test results confirming Bardet-Biedl syndrome, if available
- Or you have four main features of Bardet-Biedl syndrome
- Or you have three main features plus two additional (secondary) features
- Your diagnoses must match the study’s established feature list
- You must not be excluded for not meeting the genetic/feature requirements
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with Bardet-Biedl syndrome (BBS) or Alström syndrome (ALMS) to spot early vision, metabolic (body chemistry/energy), and kidney problems. You may be asked to have clinical checks over time to help researchers better understand how these complications develop.
This trial tests a drug called setmelanotide for people with Bardet-Biedl Syndrome (a rare genetic condition) or other severe genetic obesity. It looks at how well the drug works in real-world settings, not just in a lab.
This study is a registry, meaning it collects information about people with inherited retinal (retina) diseases. It may help researchers learn how these conditions progress and connect you with future studies or treatments.
This study is for people who have a rare syndrome or rare congenital condition and are seen at a rare-disease clinic. It aims to better understand these conditions and how care works in a team setting, which may help guide future treatment decisions.
This study looks at medical records, imaging, and genetic testing for people with autosomal recessive polycystic kidney disease (ARPKD). It may help researchers better understand the condition and how it affects the liver and kidneys.
This report describes a rare case of Bardet-Biedl syndrome in a teenager from Syria. The trial is open to anyone, so it may help doctors learn more about this condition.
Hear when a new Bardet Biedl Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.